Evidence map›Paper›PMID 31768548›Full record

ArticleProtein engineering, design & selection : PEDS2019

Amyloidogenicity and cytotoxicity of des-Lys-1 human amylin provides insight into amylin self-assembly and highlights the difficulties of defining amyloidogenicity.

Kyung-Hoon Lee, Alexander Zhyvoloup, Daniel Raleigh

Open access · greenAbstract read
In one paragraph

Article in Protein engineering, design & selection : PEDS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Kyung-Hoon LeeDepartment of Chemistry, Stony Brook University, Stony Brook, NY 11790-3400, USA.
Alexander ZhyvoloupInstitute of Structural and Molecular Biology, University College London, Gower Street, London WC1E6BT, UK, and.
Daniel RaleighDepartment of Chemistry, Stony Brook University, Stony Brook, NY 11790-3400, USA.
Institute of Structural and Molecular Biology · GBStony Brook University · USUniversity College London · GB

Funding

Biophysical Studies of Amyloid Formation by Polypeptide HormonesR01GM078114 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI RALEIGH, DANIEL P · 2008 to 2024
$5.1M
NIGMS NIH HHS R01 GM078114
6 · The paper itself

Abstract

The polypeptide amylin is responsible for islet amyloid in type 2 diabetes, a process which contributes to β-cell death in the disease. The role of the N-terminal region of amylin in amyloid formation is relatively unexplored, although removal of the disulfide bridged loop between Cys-2 and Cys-7 accelerates amyloid formation. We examine the des Lys-1 variant of human amylin (h-amylin), a variant which is likely produced in vivo. Lys-1 is a region of high charge density in the h-amylin amyloid fiber. The des Lys-1 polypeptide forms amyloid on the same time scale as wild-type amylin in phosphate buffered saline, but does so more rapidly in Tris. The des Lys-1 variant is somewhat less toxic to cultured INS cells than wild type. The implications for the in vitro mechanism of amyloid formation and for comparative analysis of amyloidogenicity are discussed.

Indexed as

Protein AggregatesAmino Acid SequenceBuffersCell LineHumansIslet Amyloid PolypeptideKineticsBuffersIslet Amyloid PolypeptideProtein AggregatesamylinamyloiddavalintideIAPPtype-2 diabetes

Identifiers

PMID31768548
PMCPMC6908818
OpenAlexW2998585388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.